Professor Joel Lexchin's co-authored study finds doctors not immune to pharmaceutical promotion

Pharmaceutical promotion may cause doctors to prescribe more expensively, less appropriately and more often, according to a new study co-authored by physician and York Professor Joel Lexchin. The findings, published Wednesday in the journal, PLoS Medicine, offer a broad look at the relationship between doctors’ prescribing habits and their exposure to information provided by drug companies. […]

Professor Joel Lexchin: Some Canadian drugs are overpriced before they are patented

Canada needs a new system for controlling drug prices that does not depend on whether or not a drug has received a patent, according to an article by York Professor Dr. Joel Lexchin. Drug prices in Canada can be unregulated for years, a period during which companies may overprice the drugs and market them, says […]